Diversified Healthcare Trust posts investor presentation
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
8-K Event Classification
AI-generated analysis. How Rhea-AI works. Not financial advice.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
(Exact Name of Registrant as Specified in Its Charter)
(State or Other Jurisdiction of Incorporation)
| (Commission File Number) | (IRS Employer Identification No.) |
(Address of Principal Executive Offices) (Zip Code)
(Registrant’s Telephone Number, Including Area Code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities Registered Pursuant to Section 12(b) of the Act:
| Title of Each Class | Trading Symbol(s) | Name Of Each Exchange On Which Registered | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
| Item 7.01. | Regulation FD Disclosure. |
On November 16, 2026, Diversified Healthcare Trust posted to its website an investor presentation, a copy of which is attached hereto as Exhibit 99.1.
| Item 9.01. | Financial Statements and Exhibits. |
| (d) | Exhibits. |
| 99.1 | Investor Presentation dated November 16, 2026. (Furnished herewith.) | |
| 104 | Cover Page Interactive Data File. (Embedded within the Inline XBRL document.) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| DIVERSIFIED HEALTHCARE TRUST | ||
| By: | /s/ Matthew C. Brown | |
| Name: | Matthew C. Brown | |
| Title: | Chief Financial Officer and Treasurer | |
Dated: November 16, 2026
Exhibit 99.1
| 1 1 NAREIT Presentation November 2026 |
| 2 2 This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other securities laws that are subject to risks and uncertainties. These statements may include words such as “believe”, “expect”, “anticipate”, “intend”, “plan”, “estimate”, “will”, “may” and negatives or derivatives of these or similar expressions. These forward-looking statements include, among others, statements about: DHC’s 2026 guidance and related assumptions, including with respect to net operating income (“NOI”), normalized funds from operations (“Normalized FFO”) and capital expenditures; DHC’s senior housing operating portfolio (“SHOP”) optimization strategy and mark-to-market opportunities and trends; the SHOP segment outlook and expected growth; the expected benefits of DHC’s SHOP lease transitions and new management agreements, including occupancy growth, reductions in capital expenditure obligations, operational efficiencies and cost savings; improvement in DHC’s balance sheet; DHC’s asset management strategies; impacts of demographic trends on DHC’s portfolio, including expected favorable senior living industry trends and related drivers; DHC’s occupancy, margin and rate growth; DHC’s strategic capital recycling plans; DHC’s cash flow trends, leverage targets and investment in portfolio upgrades and growth initiatives; DHC’s ratings outlook; and the performance of its SHOP, Medical Office and Life Science Portfolio and Triple Net Leased Senior Living and Wellness Centers portfolios; demand for medical office and life science properties, including outpatient medical spaces, and senior living communities. Forward-looking statements reflect DHC’s current expectations, are based on judgments and assumptions, are inherently uncertain and are subject to risks, uncertainties and other factors, which could cause DHC’s actual results, performance or achievements to differ materially from expected future results, performance or achievements expressed or implied in those forward-looking statements. Some of the risks, uncertainties and other factors that may cause DHC’s actual results, performance or achievements to differ materially from those expressed or implied by forward-looking statements include, but are not limited to, the following: the impact of unfavorable market and commercial real estate industry conditions due to possible reduced demand for healthcare related space and senior living communities, uncertainties surrounding interest rates, wage and commodity price inflation, supply chain disruptions, volatility in the public debt and equity markets, changing tariffs and trade policies and related uncertainty, geopolitical instability and tensions, pandemics, any U.S. government shutdown, economic downturns or a possible recession, labor market conditions or changes in real estate utilization, among other things, on DHC and its managers and other operators and tenants; DHC’s senior living operators’ abilities to successfully and profitably operate the communities they manage for DHC; DHC’s ability to transition senior living communities on the expected timeline and/or with the anticipated transition costs; the continuing impact of changing market practices on DHC and its managers and other operators and tenants, such as reduced demand for leased medical office, life science and other space of DHC and residencies at senior living communities and increased operating costs; the financial strength of DHC’s managers and other operators and tenants; whether the aging U.S. population and increasing life spans of seniors will increase the demand for senior living communities and other medical and healthcare related properties and healthcare services, including outpatient medical properties; whether DHC’s tenants will renew or extend their leases or whether DHC will obtain replacement tenants on terms as favorable to DHC as its prior leases; the likelihood that DHC’s tenants and residents will pay rent or be negatively impacted by continuing unfavorable market and commercial real estate industry conditions; DHC’s managers’ abilities to increase or maintain rates charged to residents of DHC’s senior living communities and manage operating costs for those communities; DHC’s ability to increase or maintain occupancy at its properties on terms desirable to DHC; DHC’s ability to increase rents when its leases expire or renew; costs DHC incurs and concessions it grants to lease its properties; risks and uncertainties regarding the costs and timing of development, redevelopment and repositioning activities, including as a result of inflation, interest rates, cost overruns, tariffs, supply chain challenges, labor shortages, construction delays or inability to obtain necessary permits or volatility in the commercial real estate markets; DHC’s ability to manage its capital expenditures and other operating costs effectively and to maintain and enhance its properties and their appeal to tenants and residents; DHC’s ability to effectively raise and balance its use of debt and equity capital; DHC’s ability to purchase cost effective interest rate caps; DHC’s ability to comply with the financial covenants under its debt agreements; DHC’s ability to make required payments on its debt; DHC’s ability to maintain sufficient liquidity, including the availability of borrowings under its secured revolving credit facility, and otherwise manage leverage; DHC’s credit ratings; DHC’s ability to sell properties at prices or returns it targets, and the timing of such sales; DHC’s ability to sell additional equity interests in, or contribute additional properties to, its existing joint ventures, or enter into additional real estate joint ventures or to attract co-venturers and benefit from DHC’s existing joint ventures or any real estate joint ventures it may enter into; DHC’s ability to acquire, develop, redevelop or reposition properties that realize its targeted returns; DHC’s ability to pay distributions to its shareholders and to maintain or increase the amount of such distributions; the ability of The RMR Group LLC (“RMR”) to successfully manage DHC; competition in the real estate industry, particularly in those markets in which DHC’s properties are located; government regulations affecting Medicare and Medicaid reimbursement rates and operational requirements; compliance with, and changes to, federal, state and local laws and regulations, accounting rules, tax laws and similar matters; exposure to litigation and regulatory and government proceedings due to the nature of the senior living and other health and wellness related service businesses; actual and potential conflicts of interest with DHC’s related parties, including DHC’s Managing Trustees, RMR, ABP Trust and others affiliated with them; limitations imposed by and DHC’s ability to satisfy complex rules to maintain DHC’s qualification for taxation as a real estate investment trust (“REIT”) for U.S. federal income tax purposes; acts of terrorism, war or other hostilities, outbreaks of pandemics or other public health safety events or conditions, global climate change or other manmade or natural disasters beyond DHC’s control; and other matters. These risks, uncertainties and other factors are not exhaustive and should be read in conjunction with other cautionary statements that are included in DHC’s periodic filings. The information contained in DHC’s filings with the Securities and Exchange Commission (“SEC”), including under the caption “Risk Factors” in its periodic reports, or incorporated therein, identifies important factors that could cause differences from the forward-looking statements in this presentation. DHC’s filings with the SEC are available on the SEC’s website at www.sec.gov. You should not place undue reliance upon DHC’s forward-looking statements. Except as required by law, DHC does not intend to update or change any forward-looking statements as a result of new information, future events or otherwise. Warning Concerning Forward Looking Statements |
| 3 3 Table of Contents Page COMPANY HIGHLIGHTS AND OUTLOOK 4 SHOP INITIATIVES 10 CAPITAL RECYCLING 12 CAPITAL AND LIQUIDITY OUTLOOK 13 SHOP SEGMENT 14 MEDICAL OFFICE & LIFE SCIENCE PORTFOLIO 24 TRIPLE NET LEASED WELLNESS CENTERS & SENIOR LIVING 30 APPENDIX 32 |
| 4 4 Company Highlights |
| 5 5 Diversified Healthcare Trust (Nasdaq: DHC) is a $6.3 billion healthcare REIT positioned at the center of one of real estate’s strongest demographic trends – the rapid growth of the 80+ population. Senior housing represents approximately two-thirds of DHC’s NOI, primarily through 199 communities operated under management agreements that give DHC direct participation in occupancy and rate gains. With new operators, aligned incentives and targeted capital investment in place, DHC’s senior housing portfolio has meaningful room to grow toward market occupancy levels. Medical office, life science and triple net leased properties add contractual income and tenant diversity. ~24,000 Senior Living Units 14 SHOP Operators Supporting an Efficient and Geographically Aligned Operating Platform 285 Healthcare Related Properties $260.7 million Near-Term Available Liquidity (2) +216% 3-Year TSR, Ranking #1 Among U.S. Listed REITs (3) 61.5% SHOP NOI Contribution (1) As of and for the three months ended September 30, 2026, unless otherwise noted. (2) Includes $150 million undrawn under DHC’s revolving credit facility and $110.7 million of total cash and cash equivalents. (3) Reflects total shareholder return as of November 6, 2026. Source: Ladenburg Thalmann & Co. Inc. DHC Today - National Healthcare REIT(1) |
| 6 6 Senior Housing Communities Well Positioned for Rising Senior Demand |
| 7 7 3Q26 Highlights 3Q26 Performance (1) Portfolio Optimization Strategy: Ensign Lease +$8million Annualized SNF Triple Net Rent 7 SNF Communities +50.4% Same Property SHOP NOI +28.4% Adjusted EBITDAre Growth 200 bps Same Property SHOP Occupancy Growth 470 bps Same Property SHOP Margin Expansion -$10 million Reduction of Recurring Capital Expenditure (Midpoint) +$5 million Same Property SHOP NOI (Midpoint) (1) Growth metrics reflect comparisons to 3Q25. (2) This updated guidance was issued on November 2, 2026 and has not been updated herewith. 807 Licensed Units Updated Guidance (2) +$4.5million Annualized CAD Upside |
| 8 8 Embedded Organic Growth: Clear Path to Continued NOI Growth in SHOP Existing Portfolio Mark-to-Market Opportunity Value-add Capital Expenditure(2) +356 units Through SNF Conversions Strong Balance Sheet Profile Improved Operator Contracts +500 - 600 bps Occupancy Upside to NIC Markets +$472 avg monthly rate Per Unit Upside to NIC Markets 2.5x YoY Leverage Improvement 0.8x YoY Interest Coverage Improvement 5.5x–6.5x Updated Leverage Outlook (3) +$2 million Initial Expected Annual Cost Savings 76 Legacy Communities 4,886 Units (1) Estimated incremental revenue with improvement to NIC market benchmark, excludes communities transitioned to Ensign triple net lease. (2) Initial projects of 13 communities and estimated capital spend of $45 million. (3) Updated leverage outlook excludes any estimated incentive fees. 14 – 16% ROI – Expected Stabilized Year NOI $180 - 195 million Occupancy and Rate Driven Incremental Revenue Upside(1) |
| 9 9 Updated Full Year 2026 Guidance(1) $0.46 - $0.52 Normalized FFO per Common Share(2)(3) (dollars and shares in thousands, except per share data) $110,700-$125,700 Normalized FFO(2)(3) $275,700-$290,700 Adjusted EBITDAre(2)(3) $312,000-$328,000 Same Property NOI $90,000-$105,000 Recurring CapEx Previous Estimated Incentive Change Updated Guidance Management Fee (3) Mid-point Guidance (3) Same Property NOI by Segment SHOP $185,000 - $195,000 $5,000 $190,000 -$200,000 Medical Office and Life Science Portfolio $94,000 - $98,000 $— $94,000 -$98,000 All Other $28,000 - $30,000 $— $28,000 -$30,000 Adjusted EBITDAre and Normalized FFO Adjusted EBITDAre (2) $300,000 - $315,000 $29,300 ($24,300) $275,700 -$290,700 Normalized FFO (2) $135,000 - $150,000 $29,300 ($24,300) $110,700 -$125,700 Normalized FFO per Share (2) $0.56 - $0.62 $0.12 ($0.10) $0.46 -$0.52 Recurring Capital Expenditures by Segment SHOP $80,000 - $90,000 ($10,000) $70,000 -$80,000 Medical Office and Life Science Portfolio $20,000 - $25,000 $— $20,000 -$25,000 All Other $— $— $— Same Property SHOP NOI Drivers (Approximate): Previous Updated Occupancy +200 bps +200 bps Revenue +6.6% +6.3% Average monthly rate +5.5% +5.6% Operating expenses +2.5% +2.3% ExPOR +1.5% +1.7% Other Assumptions (Approximate): Mid-point General and administrative expense $61,800 Incentive management fee (included in G&A) (3) $29,300 Unconsolidated joint ventures' EBITDAre $18,300 Interest expense $149,000 Weighted average shares 242,000 (1) DHC does not reconcile the non-GAAP measures in its annual guidance or long term outlook because significant information, most notably impairment of assets, gain (loss) on sale of real estate, loss on modification or early extinguishment of debt and equity in net earnings of investees, is not available without unreasonable efforts, or at all. These items are not indicative of DHC’s ongoing operations, are uncertain and could materially impact DHC’s GAAP results for the guidance period. This guidance was issued on November 2, 2026 and has not been updated herewith. (2) Beginning with the third quarter of 2026, Adjusted EBITDAre and Normalized FFO include estimated incentive management fees recognized under GAAP, if any. DHC’s previously issued guidance excluded this fee. (3) Reflects the impact of the estimated full year 2026 incentive management fee of $29,300, or $0.12 per share, as of September 30, 2026. |
| 1010 Senior Housing, 51.9% Strategic Initiatives Driving Outsized Growth of SHOP Segment +1,470 bps year over year increase in SHOP segment NOI contribution Operational Improvement ➢ Revenue management: Market-based pricing, room-type premiums and tighter concession controls to capture rate. ➢ Care-level accuracy: Regular resident reassessments so care revenue reflects the care actually delivered. ➢ Operator purchasing scale: Communities benefit from each operator’s broader purchasing reach across its own portfolio, which lowered dietary expense ~$1.3 million year over year. Capital Recycling ➢ Concentrating in SHOP:Non-core sales have reduced medical office exposure while SHOP NOI growth has accelerated, shifting the portfolio toward its highest-growth segment. ➢ Shifting operating risk: Transitioning the majority of SHOP skilled nursing communities to a triple net lease, increasing cash flow and shifting operating and capital costs to the tenant. ➢ Funding higher-return projects: Directing proceeds and capital to unit conversions and repositioning within the existing portfolio. % of NOI 3Q25 NOI Wellness, 6.0% Life Science, 13.8% Medical Office, 28.3% SHOP, 46.8% NNN, 5.1% Senior Housing, 65.8% % of NOI 3Q26 NOI Wellness, 4.6% Life Science, 9.3% Medical Office, 20.3% SHOP, 61.5% NNN, 4.3% |
| 1111 5.8% 6.9% 5.9% 5.7% 5.6% 6.3% 0.5% 4.0% 4.2% 1.7% 75.9% 79.6% 80.9% 81.9% 83.9% 50% 55% 60% 65% 70% 75% 80% 85% 90% -2% 0% 2% 4% 6% 8% 10% 12% 14% 2022A 2023A 2024A 2025A 2026E Occupancy RevPOR / ExPOR Growth RevPOR Y/Y ∆% ExPOR Y/Y ∆% Occupancy % 2026E SHOP Margin Expansion is Expected to Continue Focused on driving continued margin expansion across the SHOP platform. SHOP RevPOR vs ExPOR and Occupancy Growth Trends (1) l (1) 2022A – 2025A reflects full year same property data. 2026E reflects full year occupancy guidance and mid-point guidance for RevPOR and ExPOR. |
| 1212 (1) Occupancy is presented as of the month preceding disposition. (2) Revenue and NOI are presented for the year ended December 31, 2025 for properties sold in 2026, and for the nine months ended September 30, 2026 for properties under agreement. Capital Recycling Update ➢ Sales of non-core properties totaled $627.9 million since 2025, boosting overall performance and driving margin expansion. ➢ As of November 2, 2026, DHC was under agreement to sell a vacant medical office property for a sales price of $10.5 million, excluding closing costs. This property generated negative NOI of $369,000 during the nine months ended September 30, 2026. SHOP MOB/Life Science Number of Properties / Units or SF 13 / 669 Units 1 / 126,225 SF Occupancy (1) 79.6% 0% Revenue (2) $29.2M $0M NOI (2) $(3.0)M $(0.4)M Price Per SF or Unit $34,380 / Unit $83.18 / SF Gross Sales Price $23.0M $10.5M Total Proceeds $23.0M $10.5M Properties Sold in 2026 Properties Under Agreement |
| 1313 DHC is updating its targeted leverage outlook to 5.5x - 6.5x (excluding estimated incentive fees) to enhance its cost of capital and improve its outlook with the rating agencies. Balance Sheet Management Update ➢ As a result of its 2025 capital markets activity, DHC extended its debt maturity runway to 2028. ➢ In October 2026, S&P revised its ratings outlook from stable to positive and in April 2026, Moody’s upgraded DHC to B3 and revised its ratings outlook from stable to positive. ➢ Almost $1.5 billion raised from diversified funding sources, highlighting DHC’s ability to tap into multiple markets. ➢ Trending towards positive cash flow as leverage declines. $0.3 $2.2 $640.6 $1.8 $435.1 $1,361.4 2026 2027 2028 2029 2030 2031 & Thereafter Unsecured Fixed Rate Debt Secured Fixed Rate Debt Secured Floating Rate Debt Balance Sheet Outlook & Liquidity Update Debt Maturity Schedule (dollars in millions) YoY Leverage Improvement [94.2%] Fixed Rate Debt $4.2 Billion Unencumbered Assets $271.8 Million Near-Term Available Liquidity 10.7x 8.2x Moody’s and S&P Global Upgrades to B3 and B-, respectively (1) (1) DHC has two one-year extension options for the maturity date of its $140 million floating rate debt, subject to satisfaction of certain conditions and payment of an extension fee. (2) Includes $150 million undrawn under DHC’s revolving credit facility and $110.7 million of total cash and cash equivalents. $260.7 Million Near-Term Available Liquidity (2) $4.0 Billion Unencumbered Assets 94.3% Fixed Rate Debt YoY Interest Coverage Improvement 1.2x 2.0x As of September 30, 2026 unless otherwise noted. |
| 1414 SHOP Segment |
| 1515 Favorable Industry Trends Support Operational Momentum ➢ Senior living demographic of 80+ population is projected to grow at a 4.1% CAGR over the next 15 years while inventory growth is expected to remain depressed at 0.38%. (1)(2) ➢ Rent growth remains elevated, with rents in top primary / secondary markets increasing up to 10% annually. ➢ Inventory growth has been decreasing since 2018. Age 80+ Population Growth(1) Inventory Growth(3) - 5.0 10.0 15.0 20.0 25.0 30.0 Millions 10 0.0% 1.0% 2.0% 3.0% 4.0% 5.0% 6.0% Senior Housing Independent Living Assisted Living Robust 80+ population growth projections coupled with meaningfully reduced senior housing supply growth since 2018 supports a favorable sector backdrop. (1) Source: Population estimates from the Organisation for Economic Co-operation and Development (OECD) as of 2026. (2) Source: National Investment Center for Seniors Housing & Care (NIC) as of 3Q26. (3) Source: NIC Map © Data Service in primary and secondary markets as of 3Q26. For more information on the NIC MAP © Data Service, please visit www.nic.org/NIC-map. |
| 1616 Senior Housing Supply-Demand Imbalance ➢ 3Q26 showed record level occupancy for Senior Housing in Primary and Secondary NIC markets at 90.6%. Industry wide low inventory growth is leading to increased supply constraints, which is driving occupancy gains. ➢ 80+ population is expected to grow 48% by 2035, ultimately outpacing the currently diminished growth of total available units. Long term senior population growth is significantly outpacing inventory growth, supporting the outlook for higher occupancy levels and rent growth. 15.21 16.32 17.19 18.01 18.79 19.59 1.17 1.17 1.18 1.18 1.19 1.19 2026 2027 2028 2029 2030 2031 (Millions) Projected U.S. 80+ Population Projected U.S. Senior Housing Units (1) Source: Population estimates from the Organisation for Economic Co-Operation and Development (OECD) as of 2026. (2) Source: National Investment Center for Seniors Housing & Care (NIC) CBSA Property Trends as of 3Q26. (1) (2) |
| 1717 0 50 100 150 200 250 1900 1902 1904 1906 1908 1910 1912 1914 1916 1918 1920 1922 1924 1926 1928 1930 1932 1934 1936 1938 1940 1942 1944 1946 1948 1950 1952 1954 1956 1958 1960 1962 1964 1966 1968 1970 1972 1974 1976 1978 1980 1982 1984 1986 1988 1990 1992 1994 1996 U.S. Population, Millions Demographic Inflection Point Accelerates Near-Term Demand (1) ➢ The oldest baby boomers begin turning 80 years old in 2026, driving a surge in senior housing demand. ➢ Decline in traditional caregiving population (55-70 years old) expected during the same 10-year period. ➢ Limited new construction benefits existing communities and in-place portfolios. +36% The baby boomer generation is rapidly entering the 80+ age range, providing ongoing senior living demand that will benefit in-place SHOP portfolios. (1) Source: Census Bureau Office, 2026. |
| 1818 SHOP Mark to Market Opportunities & Trends ➢ Strategically located properties with ~60% of communities renovated in the last 3 years. ➢ RevPOR and Occupancy grew 19% and 930 basis points, respectively, since 2022 with active rate optimization and higher-volume sales strategies. ➢ 500 - 600 basis point occupancy and $472 average monthly rate per unit mark to market opportunity across DHC’s current portfolio. $521,798 $352,408 $509,445 $340,337 Primary Secondary SHOP Market 65+ Average Home Value (1) The average DHC resident home value is 2.4% higher than the average in primary markets and 3.5% higher than the average in secondary markets, supporting long-term affordability and resident retention. SHOP Occupancy Market Potential (2) SHOP Rate Market Potential (2) (1) Compares home values within 3-mile radius using NIC MAPs analysis feature as of 3Q26, excludes communities transitioned to Ensign lease. (2) Figures are for each respective full year and National Investment Center for Seniors Housing & Care (NIC) Market Trends data as of 3Q26, 3Q26 excludes communities transitioned to Ensign lease. 74.4% 78.1% 79.3% 81.0% 83.7% 89.2% 2022 2023 2024 2025 3Q26 NIC Market $4,571 $4,888 $5,179 $5,467 $5,460 $5,932 2022 2023 2024 2025 3Q26 NIC Market |
| 1919 Operates in 10 States across the U.S. Southeast Top Operators by DHC Unit Count Snapshot (1) 446 Communities 50,000+ Senior Living Units ~27,000 Employees Largest U.S. Senior Living Operator 130+ Communities 16,000+ Senior Living Units ~85% Average Occupancy 10th Largest U.S. Senior Living Operator 43 Communities 3,700+ Employees 5,600+ Resident Capacity 106 Communities 9,700+ Senior Living Units ~95% Average Occupancy 40 years of community transition experience 55 Communities 4,000+ Senior Living Units 2,800+ Employees 70+ Communities 5,500+ Senior Living Units 41st Largest U.S. Senior Living Operator Rapid growth since its founding in 2016 Operates in 9 States across the U.S. (1) Source: Company data, American Seniors Housing Association Awards. |
| 2020 Five Star Senior Living, 17,287 Other, 1,821 Charter Senior Living, 1,759 Phoenix Senior Living, 1,457 Oaks-Caravita Senior Care, 1,415 Stellar Senior Living, 1,133 3Q26 Occupancy NIC Benchmark 80.1% 86.9% 92.4% 83.9% 85.1% 85.7% 82.3% 89.4% 89.7% 90.5% 90.2% 89.3% 92.1% 91.4% Sinceri Discovery WellQuest Stellar Tutera Phoenix Ciel Sinceri Senior Living, 7,248 Other, 1,814 WellQuest Living, 791 Charter Senior Living, 1,758 Phoenix Senior Living, 1,800 Tutera, 1,941 Stellar Senior Living, 1,987 Discovery Senior Living, 5,106 Transition Communities Opportunities (1) Occupancy upside is the gap between the pro forma 3Q26 occupancy and the applicable NIC benchmark data calculated using Core-Based Statistical Areas, or CBSAs, where the 116 communities are located and additional market data for non-CBSA properties, weighted by units. 2025 Transition Communities Occupancy Upside Potential Recent Transition Communities Occupancy Upside (1) Pre-Transition SHOP Units by Operator 3Q26 SHOP Units by Operator ➢ Implementing dynamic pricing structures and expanding ancillary services to boost occupancy and elevate resident care. ➢ Leveraging regional densification to reduce structural labor costs and improve operational efficiency. ➢ Driving savings through centralized purchasing to lower fees and dietary expenses. ➢ Capturing uplift from recently renovated and modernized communities. |
| 2121 DHC Portfolio Operator Footprint Discovery Sinceri Charter Phoenix Oaks Tutera Stellar Northstar Navion WellQuest Other DHC’s SHOP segment is broadly diversified both geographically and by operator. Management is focused on clustering communities to drive operational synergies. SHOP Segment Geographic Diversification by Operator/Unit Count Note: Bubble sizes reflect DHC’s unit count in identified market as of September 30, 2026. |
| 2222 DHC Active Asset Management Capabilities Active Asset Management Cadence driven asset management to navigate operators towards performance objectives. Continuous evaluation of assets for capital improvements and/or capital recycling. Other areas of cross functional support exist for all aspects of real estate investment decisions. Analytics Driving Performance Use of proprietary and market data leveraged across all systems to support portfolio wide actionable decisions backed by RMR’s network of over 800 CRE professionals. Experienced Operators Performance based incentives are in place to drive growth and ensure resident satisfaction, aligning goals between DHC and its experienced operators. |
| 2323 Recent SHOP Completed Capital Projects (1) • Units: 343 • Occupancy: 90.1% • Project Cost: $10,000,000 • ROI (2): 72.3% Community-wide enhancements completed to elevate market appeal through refreshed common areas, an upgraded dining experience, an improved main entrance arrival, modernized corridors and updated FF&E and signage, creating a cohesive, hospitality-forward environment to support resident satisfaction and sustained rate growth. • Units: 236 • Occupancy: 77.4% • Project Cost: $6,352,000 • ROI (2): 19.4% Targeted renovations that elevated the community’s presentation and functionality through refreshed common areas, an upgraded lobby, enhanced dining rooms and corridors and improvements to the resident bridge. FF&E and signage updates, along with main entry enhancements, modernized the environment and improved the community’s ability to drive occupancy improvement and rate growth. • Units: 273 • Occupancy: 85.8% • Project Cost: $2,596,000 • ROI (2): 33.6% This targeted refresh included updating common area FF&E, flooring, paint, window treatments, artwork and signage to modernize the community and strengthen brand perception at a relatively low cost. The improvements will support faster leasing, rent premiums, and better resident retention while reducing maintenance and operational friction. Overall, the scope is intended to deliver a high impact upgrade that extends the asset’s competitive life and generates an attractive return. The Remington Club, CA The Pines of Dayton Place, CO The Pointe at Plantation, FL (1) Data as of September 30, 2026. (2) ROI is calculated from NOI 12 months before construction and Q3 2026 NOI annualized over total project cost. |
| 2424 Medical Office & Life Science Segment |
| 2525 Medical Office & Life Science Portfolio Overview (1) (1) Portfolio information represents same store properties as of September 30, 2026. (2) Q3 2026 cash basis NOI annualized. (3) By annualized rental income as of September 30, 2026. Outpatient Medical 42 Properties 2.6 Million SF 94% Occupancy Medical Support 9 Properties 1.4 Million SF 95% Occupancy Life Science Lab & R&D 10 Properties 926,000 SF 100% Occupancy Research Support 3 Properties 261,000 SF 76% Occupancy Medical Office Diverse tenant mix providing a wide range of outpatient services from high acuity specialty to primary care and dental, as well as health system administration, medical supplies and health insurance providers. Life Science High-quality, well-located laboratory and R&D assets with a strong tenant base within the biotechnology, pharmaceutical development and medical device industries. 51 Properties 4.0 Million Square Feet $63.5 Million Annual Cash Basis NOI (2) 5.1 Years WALT (3) 13 Properties 1.2 Million Square Feet $28.0 Million Annual Cash Basis NOI (2) 5.2 Years WALT (3) 89% Health System Affiliated (3) 72% of Cash Basis NOI from Top 3 Life Science Markets (2) 69% Investment Grade Credit (3) 100% Investment Grade Credit (3) |
| 2626 Portfolio information represents same store properties as of September 30, 2026. Sources: Statista, CMS, Grandview Research, KFF ‘Key Facts About Hospitals’. (1) Based on the three months ended September 30, 2026, compared with the same period ended September 30, 2025. (2) By annualized rental income as of September 30, 2026. (3) Data per 1,000 people per KFF ‘Key Facts About Hospitals’ published February 2025. 2.5% YoY NOI Growth (1) 89% Health System Affiliated(2) 55% Investment Grade Tenancy (2) Outpatient Medical – Additional Portfolio Detail 94% Occupancy 83% Off-Campus Properties Portfolio Highlights 21 Spurs Lane San Antonio, TX ➢ Growing demand for healthcare services and increased spending, driven by an aging population and advancements in medical care. ➢ Outpatient utilization has grown 31% since 2000 while inpatient has declined 19%. (3) o Trend expected to continue driven by consumer preference for greater convenience, lower costs for providers and insurers and advancements enabling more formerly inpatient-only procedures to be performed in outpatient facilities. ➢ Federal healthcare spending reductions present risks and opportunities as providers seek more affordable care delivery options driving further demand for outpatient space. DHC’s Outpatient Medical portfolio is positioned to provide investor value from predictable cash flows, durable occupancy and resilient total returns through cycles.. DHC’s Outpatient Medical portfolio consists of 42 properties and more than 225 individual tenants that include investment grade credit rated healthcare systems, physicians' groups, primary care providers and high acuity specialty providers. 7809 W. 38th Avenue Wheat Ridge, CO |
| 2727 Medical Support Portfolio 4027 Martinsburg Pike Clear Brook, VA 18302 Talavera Ridge San Antonio, TX 69% Investment Grade Credit(1) 5.1 Years WALT Remaining 1.4M Square Feet 95% Occupancy 9 Properties A/A Median Credit Rating 10800 Nuckols Road Glen Allen, VA Portfolio information represents same store properties as of September 30, 2026. (1) By annualized rental income as of September 30, 2026. (2) Tenants providing outpatient clinical services within a property that is majority occupied by medical support or other tenants. Consistent high occupancy and strong tenant credit profile 77% of tenants in the medical services and supporting healthcare industries Well-located properties, 2009 average property vintage year Portfolio Highlights Tenant Profile (1) (2) Health Systems & Insurance, 29% Other, 23% Medical Devices, 40% Medical Associations, 2% Clinical Outpatient, 6% |
| 2828 Top 10 Health System Relationships1 Advocate Health HCA Healthcare Hawai’i Pacific Health NYU Langone Health Ascension Franciscan Health Covenant Health Sentara Health Penn State Health Emory Healthcare Top 10 Health System Relationships (1) Broad Relationships with Leading Health Systems and Major Healthcare Companies across all Medical Office Portfolio Markets Key Relationships in Each Portfolio MSA Boston Boston Children’s Hospital Atlanta Emory Healthcare Wellstar Health System Northside Hospital Milwaukee Advocate Health Albuquerque Presbyterian Healthcare Services San Antonio HCA Healthcare Medtronic Richmond Sentara Health Long Island NYU Langone Health Honolulu Hawaii Pacific Health Houston Houston Methodist Hospital Kansas City University of Kansas Health System Orlando Orlando Health Advent Health Austin Ascension Texas Children’s Hospital Indianapolis Franciscan Health St. Louis WashU Medicine Pittsburgh UPMC Denver HCA Healthcare Winchester McKesson Lubbock Covenant Health South Florida Baptist Health South Florida Dallas/Fort Worth Baylor Scott & White Health Cardinal Health Nashville HCA Healthcare Harrisburg Penn State Health Philadelphia Jefferson Health (1) By annualized rental income from direct and affiliated leases as of September 30, 2026. |
| 2929 Life Science Portfolio ➢ Chronic disease prevalence and an aging population are driving demand for pharmaceuticals. ➢ Looming patent expirations in 2028 are forcing major pharmaceutical companies to seek ways to replace future lost revenue and encouraging greater M&A activity. ➢ Major pharmaceutical companies with advanced clinical trial successes are expected to be a leading source of new space demand. ➢ The State Street SPDR S&P Biotech ETF—widely viewed as a key barometer for biotech equity valuations—has experienced significant growth in the past 12 months. Historically, movements in this index have signaled rising leasing demand for laboratory and R&D facilities. ➢ The remaining construction pipeline of speculative lab/R&D space will be delivered in 2026, stabilizing the supply/demand balance and moving toward positive net absorption. DHC’s Life Science portfolio consists of pharmaceutical and biotechnology wet lab research facilities, medical device R&D and manufacturing facilities and research support properties. State Street SPDR S&P Biotech ETF Lab Space Under Construction (All US) 0 5 10 15 20 25 30 35 4Q20 4Q21 4Q22 4Q23 4Q24 4Q25 SF Millions $40 $60 $80 $100 $120 $140 $160 $180 10 Properties 926,000 SF 100% Occupancy Lab & R&D Facilities 6 Tenant HQ Locations 71% of Annualized Rental Income (1) 72% Located in Top 3 life science market clusters (2) 3 Properties 261,000 SF 76% Occupancy 100% Investment Grade Tenancy (1) Research Support Portfolio information represents same store properties as of September 30, 2026. Sources: Statista, CMS, Grandview Research, JLL, CBRE Research. (1) By annualized rental income as of September 30, 2026. (2) Boston, Bay Area and San Diego. Based on trailing three months annualized cash basis NOI as of September 30, 2026. |
| 3030 Triple Net Leased Wellness Centers & Senior Living |
| 3131 Triple Net Leased Wellness Centers & Senior Living Portfolio Overview Stable performance outlook with embedded growth through a mix of contracted rental increases and percentage rent. 1,328 Units 100% Occupancy 8.0 year WALT (2) 2.27x Rent Coverage (3) 812,000 SF 100% Occupancy 13.5 year WALT (2) 3.46x Rent Coverage (3) - - - 1.8% 98.2% 2026 2027 2028 2029 2030 & Thereafter NNN Lease Expiration Schedule (1) NNN Senior Living (1) NNN Wellness Centers (1) Excludes 15-year Ensign lease signed October 1, 2026. (2) By annualized rental income as of September 30, 2026. (3) Based on the three months ended September 30, 2026. The Stratford 2460 Glebe Street, Carmel, IN LifeTime Fitness 971 State Hwy 121, Allen, TX |
| 3232 Appendix |
| 3333 (1) Certifications as of December 31, 2025. Our business strategy for our Medical Office and Life Science Portfolio incorporates a focus on sustainable approaches to operating these properties in a manner that benefits our shareholders, tenants and the communities in which we are located. We seek to operate those properties in ways that improve the economic performance of their operations, while simultaneously ensuring tenant comfort and safety and managing energy and water consumption, as well as greenhouse gas emissions. Our strategy for our SHOP segment is to work with our operators to prioritize the safety and well-being of our residents, while also seeking to maximize the operating efficiencies of our senior living communities. Impact Through Action Green Building Certifications (1) Dedicated Leadership 3333 18 PROPERTIES 1.8 MILLION SF GREEN LEASE LEADERS — GOLD PARTNER 24 PROPERTIES 3.6 MILLION SF 9 PROPERTIES 0.8 MILLION SF DHC’s Board of Trustees DHC’s Board of Trustees demonstrates a strong dedication to environmental and sustainable initiatives and embodies a rich diversity in professional experience and national background, leveraging a wide range of expertise and perspective. Learn more about the Sustainability programs of our manager, The RMR Group, through its most recently published Sustainability Report. 71% Independent 29% Underrepresented Communities DHC’s Commitment to Sustainability and Good Governance 43% Women |
| 3434 Private Clients DHC is managed by The RMR Group LLC, an alternative asset manager Approximately $37 Billion in AUM RMR Platform Over 800 Real Estate Professionals More Than 30 Offices Nationwide Over 1,700 Properties National Multi-Sector Investment Platform Industrial Residential Senior Living Medical Office Life Science Hotels Retail Office RMR Clients Perpetual Capital Private Real Estate Vehicles Private Capital 34 |
| 3535 National Vertically Integrated Real Estate Operating Platform is a Differentiator and Competitive Advantage RMR Shared Services Accounting & Finance Marketing Human Resources Investor Relations Property Management Tax Development & Construction Legal Technology Acquisitions Portfolio Management Asset Management Transactions Energy & Sustainability 3535 |
| 3636 Management Aligned with Shareholder Interests RMR base management fee tied to DHC share price performance • Consists of an annual fee based on 50 bps of the lower of: (1) DHC’s historical cost of real estate, or (2) DHC’s total market capitalization. • There is no incentive for RMR to complete any transaction that could reduce DHC’s share price. RMR incentive fees are contingent on total shareholder return outperformance • Equal to 12% of value generated by DHC in excess of the benchmark index total returns (MSCI U.S. REIT/Health Care REIT Index) per share over a three-year period, subject to a cap (1.5% of equity market cap). • Outperformance must be positive: it can’t be the best of the worst. • Shareholders keep 100% of benchmark returns and at least 88% of returns in excess of the benchmark. Other fees • Property management fee: consists of an annual fee based on 3.0% of rents collected at DHC’s medical office, life science and active adult properties. • Construction supervision fee based on project costs. Alignment of Interests If DHC’s total market cap exceeds historical cost of real estate, base fee is paid on assets. If DHC’s total market cap is less than historical cost of real estate, base fee fluctuates with share price. Incentive fee structure keeps RMR focused on increasing total shareholder return. Members of RMR senior management are holders of DHC shares. DHC shareholders have visibility into publicly traded RMR. DHC benefits from RMR’s national footprint and economies of scale of a $37 billionplatform. |
| 3737 (dollars in thousands) Calculation and Reconciliation of Non-GAAP Financial Measures For the Three Months Ended For the Nine Months Ended 9/30/2026 6/30/2026 3/31/2026 12/31/2025 9/30/2025 9/30/2026 9/30/2025 Calculation of NOI and Cash Basis NOI: Rental income $ 47,748 $ 47,466 $ 49,246 $ 56,157 $ 55,316 $ 144,460 $ 169,041 Residents fees and services 319,922 317,921 317,225 323,414 333,390 955,068 989,241 Total revenues 367,670 365,387 366,471 379,571 388,706 1,099,528 1,158,282 Property operating expenses (286,907) (280,944) (290,556) (307,047) (325,387) (858,407) (952,293) NOI 80,763 84,443 75,915 72,524 63,319 241,121 205,989 Non-cash adjustments (1,613) (211) (905) (1,771) (620) (2,729) (1,873) Cash Basis NOI $ 79,150 $ 84,232 $ 75,010 $ 70,753 $ 62,699 $ 238,392 $ 204,116 Reconciliation of Net Loss to NOI and Cash Basis NOI: Net loss $ (50,229) $ (37,419) $ (43,275) $ (21,221) $ (164,040) $ (130,923) $ (264,665) Equity in net earnings of investees (2,706) (1,850) (96) (27,108) (5,083) (4,652) (9,652) Income tax expense 724 1,297 622 514 337 2,643 1,229 Loss on modification or early extinguishment of debt — — — 2,138 11,191 — 40,388 Interest expense 37,164 37,083 37,045 46,855 48,886 111,292 157,643 Interest income and other expenses (431) (258) (233) (1,532) 774 (922) (4,307) Gain on insurance recoveries — — — — — — (7,522) Loss (gain) on sale of real estate 893 629 1,207 (13,759) (1,260) 2,729 (103,971) Impairment of assets 14,543 — — 2,994 93,243 14,543 162,708 Acquisition and certain other transaction related costs 3,300 3,086 3,693 9,099 1,158 10,079 1,257 General and administrative 14,643 19,333 14,038 12,536 12,789 48,014 32,966 Depreciation and amortization 62,862 62,542 62,914 62,008 65,324 188,318 199,915 NOI 80,763 84,443 75,915 72,524 63,319 241,121 205,989 Non-cash adjustments (1,613) (211) (905) (1,771) (620) (2,729) (1,873) Cash Basis NOI $ 79,150 $ 84,232 $ 75,010 $ 70,753 $ 62,699 $ 238,392 $ 204,116 |
| 3838 Calculation and Reconciliation of Non-GAAP Financial Measures – NOI (dollars in thousands) For the Three Months Ended 9/30/2026 6/30/2026 3/31/2026 12/31/2025 9/30/2025 SHOP Revenues $ 319,922 $ 317,921 $ 317,225 $ 323,414 $ 333,390 Property operating expenses (270,261) (264,426) (273,599) (287,221) (303,770) NOI 49,661 53,495 43,626 36,193 29,620 NOI of properties not included in same property results (1,651) (1,520) 695 2,098 2,311 Same property NOI $ 48,010 $ 51,975 $ 44,321 $ 38,291 $ 31,931 Medical Office and Life Science Portfolio Revenues $ 40,397 $ 40,116 $ 41,895 $ 47,789 $ 48,201 Property operating expenses (16,526) (16,407) (16,831) (19,677) (21,526) NOI 23,871 23,709 25,064 28,112 26,675 NOI of properties not included in same property results 488 (229) (273) (4,475) (3,152) Same property NOI $ 24,359 $ 23,480 $ 24,791 $ 23,637 $ 23,523 All Other Revenues $ 7,351 $ 7,350 $ 7,351 $ 8,368 $ 7,115 Property operating expenses (120) (111) (126) (149) (91) NOI 7,231 7,239 7,225 8,219 7,024 NOI of properties not included in same property results (185) (185) (186) (62) — Same property NOI $ 7,046 $ 7,054 $ 7,039 $ 8,157 $ 7,024 Total Revenues $ 367,670 $ 365,387 $ 366,471 $ 379,571 $ 388,706 Property operating expenses (286,907) (280,944) (290,556) (307,047) (325,387) NOI 80,763 84,443 75,915 72,524 63,319 NOI of properties not included in same property results (1,348) (1,934) 236 (2,439) (841) Same property NOI $ 79,415 $ 82,509 $ 76,151 $ 70,085 $ 62,478 |
| 3939 Calculation and Reconciliation of Non-GAAP Financial Measures –Cash Basis NOI (dollars in thousands) For the Three Months Ended 9/30/2026 6/30/2026 3/31/2026 12/31/2025 9/30/2025 SHOP NOI $ 49,661 $ 53,495 $ 43,626 $ 36,193 $ 29,620 Non-cash adjustments — — — — — Cash Basis NOI 49,661 53,495 43,626 36,193 29,620 Cash Basis NOI of properties not included in same property results (1,651) (1,520) 695 2,098 2,311 Same property Cash Basis NOI $ 48,010 $ 51,975 $ 44,321 $ 38,291 $ 31,931 Medical Office and Life Science Portfolio NOI $ 23,871 $ 23,709 $ 25,064 $ 28,112 $ 26,675 Non-cash adjustments (1,516) (44) (711) (1,587) (424) Cash Basis NOI 22,355 23,665 24,353 26,525 26,251 Cash Basis NOI of properties not included in same property results 513 (266) (310) (3,019) (3,014) Same property Cash Basis NOI $ 22,868 $ 23,399 $ 24,043 $ 23,506 $ 23,237 All Other NOI $ 7,231 $ 7,239 $ 7,225 $ 8,219 $ 7,024 Non-cash adjustments (97) (167) (194) (184) (196) Cash Basis NOI 7,134 7,072 7,031 8,035 6,828 Cash Basis NOI of properties not included in same property results (134) (139) (139) (44) — Same property Cash Basis NOI $ 7,000 $ 6,933 $ 6,892 $ 7,991 $ 6,828 Total NOI $ 80,763 $ 84,443 $ 75,915 $ 72,524 $ 63,319 Non-cash adjustments (1,613) (211) (905) (1,771) (620) Cash Basis NOI 79,150 84,232 75,010 70,753 62,699 Cash Basis NOI of properties not included in same property results (1,272) (1,925) 246 (965) (703) Same property Cash Basis NOI $ 77,878 $ 82,307 $ 75,256 $ 69,788 $ 61,996 |
| 4040 Calculation and Reconciliation of Non-GAAP Financial Measures (dollars in thousands) For the Three Months Ended For the Nine Months Ended 9/30/2026 6/30/2026 3/31/2026 12/31/2025 9/30/2025 9/30/2026 9/30/2025 Net loss $ (50,229) $ (37,419) $ (43,275) $ (21,221) $ (164,040) $ (130,923) $ (264,665) Interest expense 37,164 37,083 37,045 46,855 48,886 111,292 157,643 Income tax expense 724 1,297 622 514 337 2,643 1,229 Depreciation and amortization 62,862 62,542 62,914 62,008 65,324 188,318 199,915 EBITDA 50,521 63,503 57,306 88,156 (49,493) 171,330 94,122 Loss (gain) on sale of real estate 893 629 1,207 (13,759) (1,260) 2,729 (103,971) Impairment of assets 14,543 — — 2,994 93,243 14,543 162,708 Equity in net earnings of investees (2,706) (1,850) (96) (27,108) (5,083) (4,652) (9,652) Share of EBITDAre from unconsolidated joint ventures 4,642 4,457 4,549 4,612 4,511 13,648 13,468 Adjustments to reflect DHC's share of EBITDAre attributable to a former equity method investment — — — — 4,831 — 7,922 EBITDAre 67,893 66,739 62,966 54,895 46,749 197,598 164,597 General and administrative expense paid in common shares 2,227 2,264 717 593 1,164 5,208 2,818 Acquisition and certain other transaction related costs 3,300 3,086 3,693 9,099 1,158 10,079 1,257 Gain on insurance recoveries — — — — — — (7,522) Loss on modification or early extinguishment of debt — — — 2,138 11,191 — 40,388 Adjustments to reflect DHC's share of Adjusted EBITDAre attributable to a former equity method investment — — — — (3,072) — (2,181) Adjusted EBITDAre (1) $ 73,420 $ 72,089 $ 67,376 $ 66,725 $ 57,190 $ 212,885 $ 199,357 (1) Beginning with the third quarter of 2026, DHC revised its calculation of Adjusted EBITDAre to include estimated incentive management fees recognized under GAAP, if any. Prior periods presented have been recast to conform to the current presentation. Adjusted EBITDAre includes incentive management fees of $5,374 for the three months ended September 30, 2026, $9,993 for the three months ended June 30, 2026, $6,628 for the three months ended March 31, 2026, $5,674 for the three months ended December 31, 2025, $5,676 for the three months ended September 30, 2025, $21,995 for the nine months ended September 30, 2026 and $12,231 for the nine months ended September 30, 2025. |
| 4141 Calculation and Reconciliation of Non-GAAP Financial Measures (dollars in thousands) For the Three Months Ended For the Nine Months Ended 9/30/2026 6/30/2026 3/31/2026 12/31/2025 9/30/2025 9/30/2026 9/30/2025 Net loss $ (50,229) $ (37,419) $ (43,275) $ (21,221) $ (164,040) $ (130,923) $ (264,665) Depreciation and amortization 62,862 62,542 62,914 62,008 65,324 188,318 199,915 Loss (gain) on sale of real estate 893 629 1,207 (13,759) (1,260) 2,729 (103,971) Impairment of assets 14,543 — — 2,994 93,243 14,543 162,708 Equity in net earnings of investees (2,706) (1,850) (96) (27,108) (5,083) (4,652) (9,652) Share of FFO from unconsolidated joint ventures 2,066 1,915 2,027 1,998 2,199 6,008 7,651 Adjustments to reflect DHC's share of FFO attributable to a former equity method investment — — — — 3,731 — 5,699 FFO 27,429 25,817 22,777 4,912 (5,886) 76,023 (2,315) Acquisition and certain other transaction related costs 3,300 3,086 3,693 9,099 1,158 10,079 1,257 Gain on insurance recoveries — — — — — — (7,522) Loss on modification or early extinguishment of debt — — — 2,138 11,191 — 40,388 Adjustments to reflect DHC's share of Normalized FFO attributable to a former equity method investment — — — — (2,418) — (1,441) Normalized FFO (1) $ 30,729 $ 28,903 $ 26,470 $ 16,149 $ 4,045 $ 86,102 $ 30,367 (1) Beginning with the third quarter of 2026, DHC revised its calculation of Normalized FFO to include estimated incentive management fees recognized under GAAP, if any. Prior periods presented have been recast to conform to the current presentation. Normalized FFO includes incentive management fees of $5,374 for the three months ended September 30, 2026, $9,993 for the three months ended June 30, 2026, $6,628 for the three months ended March 31, 2026, $5,674 for the three months ended December 31, 2025, $5,676 for the three months ended September 30, 2025, $21,995 for the nine months ended September 30, 2026 and $12,231 for the nine months ended September 30, 2025. |
| 4242 Calculation and Reconciliation of Non-GAAP Financial Measures (dollars in thousands, except per share data) For the Three Months Ended For the Nine Months Ended 9/30/2026 6/30/2026 3/31/2026 12/31/2025 9/30/2025 9/30/2026 9/30/2025 Normalized FFO $ 30,729 $ 28,903 $ 26,470 $ 16,149 $ 4,045 $ 86,102 $ 30,367 General and administrative expense paid in common shares 2,227 2,264 717 593 1,164 5,208 2,818 Non-cash interest expense 2,306 2,309 2,329 11,848 20,121 6,944 66,094 Non-cash amortization included in expenses (943) (943) (943) (942) (943) (2,829) (2,828) Non-cash straight line rent adjustments included in rental income 105 204 (57) (203) (450) 252 (759) Lease value amortization included in rental income 5 29 29 30 29 63 83 Recurring capital expenditures (26,146) (22,928) (18,728) (35,071) (40,562) (67,802) (96,377) Share of FFO from unconsolidated joint ventures (2,066) (1,915) (2,027) (1,998) (2,199) (6,008) (7,651) Adjustments to reflect DHC's share of FFO and Normalized FFO attributable to a former equity method investment — — — — (1,313) — (4,258) Unconsolidated joint venture distributions (1) 600 600 600 750 28,250 1,800 28,250 Former equity method investment distribution — — 27,200 — 3,400 27,200 20,400 CAD (2) $ 6,817 $ 8,523 $ 35,590 $ (8,844) $ 11,542 $ 50,930 $ 36,139 Weighted average common shares outstanding (basic and diluted) 240,980 240,749 240,689 240,662 240,385 240,809 240,160 Per common share data (basic and diluted): Net loss $ (0.21) $ (0.16) $ (0.18) $ (0.09) $ (0.68) $ (0.54) $ (1.10) FFO $ 0.11 $ 0.11 $ 0.09 $ 0.02 $ (0.02) $ 0.32 $ (0.01) Normalized FFO (3) $ 0.13 $ 0.12 $ 0.11 $ 0.07 $ 0.02 $ 0.36 $ 0.13 CAD (3) $ 0.03 $ 0.04 $ 0.15 $ (0.04) $ 0.05 $ 0.21 $ 0.15 (1) In August 2025, DHC received a cash distribution of $28,000 from the Seaport Innovation LLC joint venture in connection with the refinancing of such joint venture's prior mortgage loan. (2) Beginning with the third quarter of 2026, DHC revised its calculation of CAD to include estimated incentive management fees recognized under GAAP, if any. Prior periods presented have been recast to conform to the current presentation and as a result CAD for the three months ended March 31, 2026 does not include a deduction for the January 2026 incentive fee payment to RMR. CAD includes incentive management fees of $5,374 for the three months ended September 30, 2026, $9,993 for the three months ended June 30, 2026, $6,628 for the three months ended March 31, 2026, $5,674 for the three months ended December 31, 2025, $5,676 for the three months ended September 30, 2025, $21,995 for the nine months ended September 30, 2026 and $12,231 for the nine months ended September 30, 2025. (3) The impact of estimated incentive management fees recognized on Normalized FFO and CAD per share was $0.02 for the three months ended September 30, 2026, $0.04 for the three months ended June 30, 2026, $0.03 for the three months ended March 31, 2026, $0.02 for the three months ended December 31, 2025, $0.02 for the three months ended September 30, 2025, $0.09 for the nine months ended September 30, 2026 and $0.05 for the nine months ended September 30, 2025. |
| 4343 NOI, Cash Basis NOI, Same Property NOI and Same Property Cash Basis NOI The calculations of NOI, Cash Basis NOI, same property NOI and same property cash basis NOI exclude certain components of net income (loss) in order to provide results that are more closely related to our property level results of operations. We calculate NOI, Cash Basis NOI, same property NOI and same property cash basis NOI as shown in this appendix. We define NOI as income from our real estate less our property operating expenses. NOI excludes depreciation and amortization. We define Cash Basis NOI as NOI excluding non-cash straight line rent adjustments, lease value amortization, lease termination fees, if any, and non-cash amortization included in property operating expenses. We calculate same property NOI and same property cash basis NOI in the same manner that we calculate the corresponding NOI and cash basis NOI amounts, except that we only include same properties in calculating same property NOI and same property cash basis NOI. We use NOI, Cash Basis NOI, same property NOI and same property cash basis NOI to evaluate individual and company-wide property level performance. Other real estate companies and REITs may calculate NOI, Cash Basis NOI, same property NOI and same property cash basis NOI differently than we do. FFO and Normalized FFO We calculate FFO and Normalized FFO as shown in this appendix. FFO is calculated on the basis defined by Nareit, which is net income (loss), calculated in accordance with GAAP, excluding any gain or loss on sale of properties, equity in net earnings or losses of investees, loss on impairment of real estate assets, gains or losses on equity securities, net, if any, and including adjustments to reflect our proportionate share of FFO from unconsolidated joint venture properties and prior to the wind-down of AlerisLife Inc.’s business, our proportionate share of FFO of our former equity method investment, plus real estate depreciation and amortization of consolidated properties, as well as certain other adjustments currently not applicable to us. In calculating Normalized FFO, we adjust for the items shown in this appendix, including similar adjustments for our unconsolidated joint ventures, if any. FFO and Normalized FFO are among the factors considered by our Board of Trustees when determining the amount of distributions to our shareholders. Other factors include, but are not limited to, requirements to maintain our qualification for taxation as a REIT, limitations in the agreements governing our debt, the availability to us of debt and equity capital, our expectation of our future capital requirements and operating performance and our expected needs for and availability of cash to pay our obligations. Other real estate companies and REITs may calculate FFO and Normalized FFO differently than we do. Non-GAAP Financial Measures We present certain "non-GAAP financial measures" within the meaning of applicable rules of the Securities and Exchange Commission, including net operating income, or NOI, Cash Basis NOI, same property NOI, same property Cash Basis NOI, earnings before interest, income tax, depreciation and amortization, or EBITDA, EBITDA for real estate, or EBITDAre, Adjusted EBITDAre, funds from operations, or FFO, and normalized funds from operations, or Normalized FFO, and cash available for distribution, or CAD. These measures do not represent cash generated by operating activities in accordance with GAAP and should not be considered alternatives to net income (loss) as indicators of our operating performance or as measures of our liquidity. These measures should be considered in conjunction with net income (loss) as presented in our consolidated statements of income (loss). We consider these non-GAAP measures to be appropriate supplemental measures of operating performance for a REIT, along with net income (loss). We believe these measures provide useful information to investors because by excluding the effects of certain historical amounts, such as depreciation and amortization, they may facilitate a comparison of our operating performance between periods and with other REITs and, in the case of NOI, Cash Basis NOI, same property NOI and same property Cash Basis NOI, reflecting only those income and expense items that are generated and incurred at the property level may help both investors and management to understand the operations of our properties. DEFINITIONS OF CERTAIN NON-GAAP FINANCIAL MEASURES Cash Available for Distribution We calculate CAD as shown on page 42. We define CAD as Normalized FFO minus our proportionate share of Normalized FFO from unconsolidated joint venture properties and our former equity method investment, plus cash flow distributions received from our unconsolidated joint ventures and equity method investment, if any, recurring real estate related capital expenditures, adjustments for other non-cash and nonrecurring items, certain amounts excluded from Normalized FFO but settled in cash, as well as certain other adjustments currently not applicable to us. CAD is among the factors considered by our Board of Trustees when determining the amount of distributions to our shareholders. Other real estate companies and REITs may calculate CAD differently than we do. EBITDA, EBITDAre and Adjusted EBITDAre We calculate EBITDA, EBITDAre and Adjusted EBITDAre as shown on page 40. EBITDAre is calculated on the basis defined by the National Association of Real Estate Investment Trusts, or Nareit, which is EBITDA, excluding any gain or loss on sale of real estate, equity in net earnings or losses of investees, loss on impairment of real estate assets, if any, and including adjustments to reflect our proportionate share of Adjusted EBITDAre from unconsolidated joint venture properties and prior to the wind-down of AlerisLife Inc.'s business, our proportionate share of EBITDAre of our former equity method investment, as well as certain other adjustments currently not applicable to us. In calculating Adjusted EBITDAre, we adjust for the items shown on page 40. Other real estate companies and REITs may calculate EBITDA, EBITDAre and Adjusted EBITDAre differently than we do. |
| 4444 Certain Definitions: Annualized Adjusted EBITDAre: Annualized Adjusted EBITDAre is Adjusted EBITDAre for the applicable quarter, excluding items that are determined on an annual basis and recognized during that quarter, such as incentive management fees and percentage rent, multiplied by four, and then adjusted to include the estimated amount of those annual items for the calendar year. The estimated amount of an annual item for the calendar year is its year to date amount, through the last day of the applicable quarter, annualized. These items, if any, are calculated annually and recognized based on estimates that may increase, decrease or reverse during the year. For that reason, DHC believes this calculation better reflects a full year of these items rather than multiplying a single quarter’s amount by four. Annualized Adjusted EBITDAre is used to calculate net debt / annualized Adjusted EBITDAre. Annualized rental income: Annualized rental income is based on rents pursuant to existing leases as of September 30, 2026. Annualized rental income includes estimated percentage rents, straight line rent adjustments and estimated recurring expense reimbursements for certain net and modified gross leases, and excludes lease value amortization. Amounts of annualized rental income for DHC's medical office and life science properties also exclude leases that expired on September 30, 2026 and 100% of rents pursuant to existing leases as of September 30, 2026 from the medical office and life science properties owned by unconsolidated joint ventures in which DHC owns an equity interest. CAGR: CAGR means compound annual growth rate. ExPOR: ExPOR, or expenses per occupied room, is calculated by dividing total operating expenses by the number of occupied units for the period presented. GAAP: GAAP is U.S. generally accepted accounting principles. Gross sales price: Gross sales price excludes closing costs. Health System Affiliated: Health System Affiliated means medical outpatient properties are considered affiliated with a health system if one or more of the following conditions are met: i) the property is defined as On-Campus, ii) a majority of the property is leased by a health system entity, iii) the property includes an ambulatory surgery center with a hospital partnership interest, or iv) at least 50% of the property’s annualized rental income in aggregate is from a) leases with hospital systems or direct subsidiaries of a hospital systems, b) leases with tenants that self-report affiliations with hospital systems, c) leases with tenants that are members of network of providers with at least ten locations, d) leases with tenants where a majority of care providers served by the leased premises are listed as providers by a hospital system, or e) leases with physician groups that are either employed, directly or indirectly by a health system, or have a significant clinical and financial affiliation with a health system. Incentive management fees: Incentive management fees are estimated and accrued during the applicable measurement period. Actual incentive management fees will be calculated based on common share total return, as defined in DHC's business management agreement, for the three year period ending December 31 of the applicable calendar year, are included in general and administrative expense in DHC's condensed consolidated statements of income (loss) and will be payable to RMR in January of the following calendar year. Interest rate: Interest rate is the rate stated in, or determined pursuant to, the contract terms and includes the effect of mark to market accounting for certain assumed mortgages and premiums and discounts on certain mortgages and secured and unsecured notes; excludes effects of debt issuance costs and the unused fee on DHC's secured revolving credit facility. Interest rate reflects the impact of interest rate caps, as applicable. CERTAIN DEFINITIONS |
| 4545 Leverage: Leverage is calculated by dividing net debt by annualized adjusted EBITDAre. Life Science Lab & R&D: Life Science Lab & R&D include properties with specialized laboratory or research and development spaces utilized for pharmaceutical, biotechnology and medical device research, development or manufacturing. Medical Office and Life Science Portfolio: Medical Office and Life Science Portfolio consists of medical office properties leased to medical providers and other medical related businesses, as well as life science properties leased to biotech laboratories and other similar tenants. DHC's medical office and life science property leases include some triple net leases where, in addition to paying fixed rents, the tenants assume the obligation to operate and maintain the properties at their expense, and some net and modified gross leases where DHC is responsible for the operation and maintenance of the properties and DHC charges tenants for some or all of the property operating costs. A small percentage of DHC's medical office and life science property leases are full-service leases where DHC receives fixed rent from its tenants and no reimbursement for its property operating costs. Medical Support: Medical Support includes medical office properties that are leased to medical related businesses such as medical device and healthcare supply, health system corporate administration, physician groups and health insurance. Properties that are only partially clinical outpatient space are also included. MOB: MOB, or Medical Office Building, includes outpatient medical and medical support properties. NNN: NNN means triple net leased. Non-cash adjustments: Non-cash adjustments include straight line adjustments, lease value amortization, lease termination fees and other non-cash amortization included in property operating expenses, if any. Non-cash interest expense: Non-cash interest expense includes the amortization of debt discounts, premiums, issuance costs and interest rate caps. Occupancy: Occupancy for DHC's SHOP segment is presented for the duration of the period shown; occupancy for DHC's Medical Office and Life Science Portfolio is presented as of the end of the period shown. Medical office and life science occupancy data includes (i) out of service assets undergoing redevelopment, (ii) space which is leased but is not occupied or is being offered for sublease by tenants and (iii) space being fitted out for occupancy. On-Campus: On-Campus is a medical outpatient property that is physically located within the boundaries of a hospital campus or the land parcel is adjacent to or directly across from a hospital campus. Outpatient Medical: Outpatient medical are properties offering ambulatory medical services such as primary and secondary care, outpatient surgery, diagnostic procedures, rehabilitation and other ancillary patient care services. These properties are frequently affiliated with a health system and may or may not be located on a hospital campus. These properties were either originally constructed or subsequently renovated specifically for use by healthcare professionals to provide services to patients. Primary markets: Primary markets are made up of 31 of the largest CBSAs in the United States. Data for primary markets is often presented aggregated. CERTAIN DEFINITIONS (Continued) |
| 4646 R&D: R&D means research and development. Rent coverage: Rent coverage is calculated using the annualized operating cash flows from DHC's triple net lease tenants' operations of DHC's properties, before subordinated charges, if any, divided by annualized rental income. DHC has not independently verified tenant operating data. Research Support: Research Support are properties that are leased to pharmaceutical, biotechnology and medical device businesses that provide research and administrative support to other laboratory or R&D facilities. RevPOR: RevPOR, or revenue per occupied room, is the average revenues generated per occupied room per month at Senior Housing Operating properties. ROI: ROI means return on investment. Same Property: As of and for the three months ended September 30, 2026, same property consists of properties owned, in service and reported in the same segment since July 1, 2025; excludes properties classified as held for sale, closed or out of service, if any, and planned dispositions and medical office and life science properties owned by unconsolidated joint ventures in which DHC owns an equity interest. Properties are included in same property once stabilized for the full period in both comparison periods presented. Secondary markets: Secondary markets are made up of 68 large CBSAs in the United States that are not included in the primary markets. Data for secondary markets is often presented aggregated. SHOP: SHOP, or Senior Housing Operating Portfolio, consists of senior living communities managed by third party senior living managers that provide short term and long term residential living and in some cases care and other services for residents where DHC pays fees to the managers to operate the communities. Properties in this segment include independent living communities, assisted living communities, active adult rental communities and SNFs. SNF: SNF is a skilled nursing facility. Square feet: Square feet measurements are subject to modest changes when space is periodically remeasured or reconfigured for new tenants. Square feet for prior periods exclude space remeasurements made subsequent to those periods. Excludes data from medical office and life science properties owned by unconsolidated joint ventures in which DHC owns an equity interest. Triple net leased senior living communities: Triple net leased senior living communities include independent and assisted living communities and SNFs. Unit count: Unit count is by the type of living units at DHC's senior living communities within its SHOP segment. WALT: WALT, or weighted average lease term, is weighted based on annualized rental income pursuant to existing leases as of September 30, 2026. YoY: YoY refers to year over year comparison to the same period in the previous year. CERTAIN DEFINITIONS (Continued) |













































